{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T09:01:38Z","timestamp":1782205298792,"version":"3.54.5"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,5,17]],"date-time":"2017-05-17T00:00:00Z","timestamp":1494979200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"European Union FP7 Health","award":["282533"],"award-info":[{"award-number":["282533"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s40272-017-0234-4","type":"journal-article","created":{"date-parts":[[2017,5,17]],"date-time":"2017-05-17T02:27:25Z","timestamp":1494988045000},"page":"487-495","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Understanding the Stability of Dopamine and Dobutamine Over 24\u00a0h in Simulated Neonatal Ward Conditions"],"prefix":"10.1007","volume":"19","author":[{"given":"Katherine","family":"Kirupakaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam","family":"Mahoney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Rabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavik A.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,17]]},"reference":[{"issue":"3","key":"234_CR1","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1542\/peds.102.3.e35","volume":"102","author":"FR Mattia","year":"1998","unstructured":"Mattia FR. Chronic physiologic instability is associated with neurodevelopmental morbidity at one and two years in extremely premature infants. Pediatrics. 1998;102(3):e35.","journal-title":"Pediatrics."},{"issue":"1","key":"234_CR2","first-page":"12","volume":"5","author":"K Patwardhan","year":"2009","unstructured":"Patwardhan K. Inotropes in term neonates. Infant. 2009;5(1):12.","journal-title":"Infant."},{"key":"234_CR3","doi-asserted-by":"publisher","unstructured":"Paradisis M, Osborn DA. Adrenaline for prevention of morbidity and mortality in preterm infants with cardiovascular compromise. Cochrane Database Syst Rev. 2004;(1):CD003958. doi: 10.1002\/14651858.CD003958.pub2 .","DOI":"10.1002\/14651858.CD003958.pub2"},{"issue":"2","key":"234_CR4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/00008480-200104000-00005","volume":"13","author":"I Seri","year":"2001","unstructured":"Seri I, Evans J. Controversies in the diagnosis and management of hypotension in the newborn infant. Curr Opin Pediatr. 2001;13(2):116\u201323.","journal-title":"Curr Opin Pediatr."},{"issue":"1","key":"234_CR5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2174\/187152512799201145","volume":"10","author":"L Mahoney","year":"2012","unstructured":"Mahoney L, Crook D, Walter KN, Sherman E, Rabe H. What is the evidence for the use of adrenaline in the treatment of neonatal hypotension? Cardiovasc Hematol Agents Med Chem. 2012;10(1):50\u201398.","journal-title":"Cardiovasc Hematol Agents Med Chem."},{"issue":"1","key":"234_CR6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00246-015-1263-9","volume":"37","author":"L Mahoney","year":"2016","unstructured":"Mahoney L, Shah G, Crook D, Rojas-Anaya H, Rabe H. A literature review of the pharmacokinetics and pharmacodynamics of dobutamine in neonates. Pediatr Cardiol. 2016;37(1):14\u201323.","journal-title":"Pediatr Cardiol."},{"issue":"12","key":"234_CR7","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.clinthera.2011.11.001","volume":"33","author":"T Lasky","year":"2011","unstructured":"Lasky T, Greenspan J, Ernst FR, Gonzalez L. Dopamine and dobutamine use in preterm or low birth weight neonates in the premier 2008 database. Clin Ther. 2011;33(12):2082\u20138.","journal-title":"Clin Ther."},{"issue":"1","key":"234_CR8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ana.410250103","volume":"25","author":"JJ Volpe","year":"1989","unstructured":"Volpe JJ. Intraventricular hemorrhage in the premature infant\u2014current concepts. Part I. Ann Neurol. 1989;25(1):3\u201311.","journal-title":"Ann Neurol."},{"issue":"4","key":"234_CR9","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1542\/peds.106.4.625","volume":"106","author":"M Tsuji","year":"2000","unstructured":"Tsuji M, Saul JP, du Plessis A, Eichenwald E, Sobh J, Crocker R, et al. Cerebral intravascular oxygenation correlates with mean arterial pressure in critically ill premature infants. Pediatrics. 2000;106(4):625\u201332.","journal-title":"Pediatrics."},{"issue":"1","key":"234_CR10","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1542\/peds.2008-2004","volume":"124","author":"H O\u2019Leary","year":"2009","unstructured":"O\u2019Leary H, Gregas MC, Limperopoulos C, Zaretskaya I, Bassan H, Soul JS, et al. Elevated cerebral pressure passivity is associated with prematurity-related intracranial hemorrhage. Pediatrics. 2009;124(1):302\u20139.","journal-title":"Pediatrics."},{"issue":"2","key":"234_CR11","first-page":"129","volume":"10","author":"V Bhatt-Mehta","year":"1990","unstructured":"Bhatt-Mehta V, Nahata M. Stability of dopamine hydrochloride injection in the presence of dobutamine hydrochloride, tolazoline hydrochloride, and theophylline injections. J Perinatol. 1990;10(2):129\u201333.","journal-title":"J Perinatol."},{"issue":"6","key":"234_CR12","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/00003246-199506000-00011","volume":"23","author":"JA Grillo","year":"1995","unstructured":"Grillo JA, Gonzalez ER, Ramaiya A, Karnes HT, Wells B. Chemical compatibility of inotropic and vasoactive agents delivered via a multiple line infusion system. Crit Care Med. 1995;23(6):1061\u20136.","journal-title":"Crit Care Med."},{"issue":"11","key":"234_CR13","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1177\/106002809502901104","volume":"29","author":"EM Allen","year":"1995","unstructured":"Allen EM, Van Boerum DH, Olsen AF, Dean JM. Difference between the measured and ordered dose of catecholamine infusions. Ann Pharmacother. 1995;29(11):1095\u2013100.","journal-title":"Ann Pharmacother."},{"issue":"1","key":"234_CR14","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/ejhpharm-2011-000027","volume":"19","author":"N Patel","year":"2012","unstructured":"Patel N, Taki M, Tunstell P, Forsey P, Forbes B. Stability of dobutamine 500\u00a0mg in 50\u00a0ml syringes prepared using a Central Intravenous Additive Service. Eur J Hosp Pharm Sci Pract. 2012;19(1):52\u20136.","journal-title":"Eur J Hosp Pharm Sci Pract."},{"issue":"5","key":"234_CR15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2710.1991.tb00322.x","volume":"16","author":"M Allwood","year":"1991","unstructured":"Allwood M. The stability of four catecholamines in 5% glucose infusions. J Clin Pharm Ther. 1991;16(5):337\u201340.","journal-title":"J Clin Pharm Ther."},{"issue":"6","key":"234_CR16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1046\/j.0269-4727.2003.00517.x","volume":"28","author":"J Braenden","year":"2003","unstructured":"Braenden J, Stendal T, Fagernaes C. Stability of dopamine hydrochloride 0.5\u00a0mg\/mL in polypropylene syringes. J Clin Pharm Ther. 2003;28(6):471\u20134.","journal-title":"J Clin Pharm Ther."},{"key":"234_CR17","volume-title":"British National Formulary for children","author":"British Medical Association and Royal Pharmaceutical Society of Great Britain","year":"2009","unstructured":"British Medical Association and Royal Pharmaceutical Society of Great Britain. British National Formulary for children. London: BMJ Group; 2009."},{"key":"234_CR18","volume-title":"British Pharmacopoeia 2016","author":"British Pharmacopoeia Commission","year":"2016","unstructured":"British Pharmacopoeia Commission. British Pharmacopoeia 2016. London: The Stationery Office Ltd.; 2016."},{"issue":"4","key":"234_CR19","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ccell.2006.08.008","volume":"18","author":"J Bullock","year":"2006","unstructured":"Bullock J, Jordan D, Gawlinski A, Henneman EA. Standardizing IV infusion medication concentrations to reduce variability in medication errors. Crit Care Nurs Clin North Am. 2006;18(4):515\u201321.","journal-title":"Crit Care Nurs Clin North Am."},{"issue":"2","key":"234_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc6813","volume":"12","author":"E Moyen","year":"2008","unstructured":"Moyen E, Camir\u00e9 E, Stelfox HT. Clinical review: medication errors in critical care. Crit Care. 2008;12(2):1.","journal-title":"Crit Care."},{"issue":"1","key":"234_CR21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1515\/CCLM.2010.017","volume":"48","author":"NB Roberts","year":"2010","unstructured":"Roberts NB, Higgins G, Sargazi M. A study on the stability of urinary free catecholamines and free methyl-derivatives at different pH, temperature and time of storage. Clin Chem Lab Med. 2010;48(1):81\u20137.","journal-title":"Clin Chem Lab Med."},{"issue":"5","key":"234_CR22","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/NAN.0000000000000064","volume":"37","author":"DP Barros","year":"2014","unstructured":"Barros DP, Fonseca FLA, Pedreira MDLG, Peterlini MAS. Hydrogen profiles of dobutamine hydrochloride and fentanyl citrate solutions according to intravenous administration systems, temperature, and luminosity conditions. J Infus Nurs. 2014;37(5):362\u20138.","journal-title":"J Infus Nurs."},{"issue":"3","key":"234_CR23","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/ajhp\/42.3.595","volume":"42","author":"K Dandurand","year":"1985","unstructured":"Dandurand K, Stennett D. Stability of dopamine hydrochloride exposed to blue-light phototherapy. Am J Health Syst Pharm. 1985;42(3):595\u20137.","journal-title":"Am J Health Syst Pharm."}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40272-017-0234-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-017-0234-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-017-0234-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T15:10:02Z","timestamp":1569337802000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40272-017-0234-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,17]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["234"],"URL":"https:\/\/doi.org\/10.1007\/s40272-017-0234-4","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,17]]}}}